Namenda
FDA Offers New Guidance on Developing Drugs for Alzheimer's Disease »
"Today, the U.S. Food and Drug Administration issued a proposal designed to assist companies developing new treatments for patients in the early stages of Alzheimer's disease, before the onset of noticeable (overt) dementia.
Alzheimer’"...
Read the FDA Offers New Guidance on Developing Drugs for Alzheimer's Disease article »
Namenda
PATIENT INFORMATION
Information for Patients and Caregivers: Caregivers should be instructed in the recommended administration (twice per day for doses above 5 mg) and dose escalation (minimum interval of one week between dose increases).
Last reviewed on RxList: 10/11/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Namenda Information
Namenda - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.






